Selpercatinib in Early-Stage RET Fusion-Positive Non-Small-Cell Lung Cancer. Wu YL, Hochmair M, Yang Y, Yang XN, et al. N Engl J Med 2026 May 31. doi: 10.1056/NEJMoa2602628.

Read + Share

Amedeo Smart

Independent Medical Education

Wu YL, Hochmair M, Yang Y, Yang XN, et al. Selpercatinib in Early-Stage RET Fusion-Positive Non-Small-Cell Lung Cancer. N Engl J Med 2026 May 31. doi: 10.1056/NEJMoa2602628.
PMID: 42223087